NIPT WITH MICRODELETION ALL CHROMOSOMES

NIPT (NON-INVASIVE PRENATAL TESTING) WITH MICRODELETION ANALYSIS IS A CUTTING-EDGE PRENATAL SCREENING METHOD THAT UTILIZES ADVANCED GENETIC TECHNOLOGY TO DETECT THE PRESENCE OF CHROMOSOMAL ABNORMALITIES, INCLUDING MICRODELETIONS, IN A DEVELOPING FETUS. UNLIKE TRADITIONAL PRENATAL SCREENING METHODS, NIPT REQUIRES ONLY A SIMPLE BLOOD DRAW FROM THE PREGNANT WOMAN AND CAN BE PERFORMED AS EARLY AS THE 10TH WEEK OF PREGNANCY. THIS NON-INVASIVE APPROACH SIGNIFICANTLY REDUCES THE RISK OF MISCARRIAGE ASSOCIATED WITH INVASIVE PROCEDURES LIKE AMNIOCENTESIS OR CHORIONIC VILLUS SAMPLING. BY IDENTIFYING POTENTIAL CHROMOSOMAL ABNORMALITIES EARLY ON, NIPT WITH MICRODELETION ANALYSIS EMPOWERS EXPECTANT PARENTS TO MAKE INFORMED DECISIONS ABOUT THEIR PREGNANCY AND PLAN FOR THE FUTURE.